Markets experienced a corrective session on Thursday, extending previous weakness amid adverse global cues. Key companies like RIL, Infosys...

Cyient approved a share buyback while reporting a sharp decline in quarterly profit due to one time charges, even as revenue remained stron...

Four companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...

Markets faced pressure on the weekly expiry day, reversing previous gains. Several companies reported their Q1 results, with IEX, SBI Life,...

His analysis suggests the current slowdown to be an entire FY24 phenomenon rather than 1H and the impact possibly extending to FY25 discret...

SBI Life has reported net profit of Rs 381 crore for the quarter ended June. The net premium income rose 19% year-on-year to Rs 13,104 crore

The Nifty futures on the Singapore Exchange were up by 0.14%, indicating a positive start to domestic equities. HCL Tech, Tata Communicatio...

Noida-based IT major will declare its quarterly results today. Alongside, the company will also be announcing its fourth interim dividend. ...

Some of the important results to be announced this week are of CG Consumer, Gland Pharma, IIFL Finance, Balaji Amines, Indus Towers, CE Inf...

Also, the board of Apollo Micro Systems will meet to consider the issue of equity shares and/or convertible securities including warrants o...

"There may not be a big rerating for the largecap names. We should focus on the midcap IT names like Mphasis, MindTree and to some extent L...

The brokerage expects capital return through a buyback in FY21 once fundamentals stabilise.

Government is looking to plug a loophole in buybacks as these are not taxed like dividend payouts.

Revenue increased 9.5 per cent to Rs 1,162.9 crore, against Rs 1,061.8 crore in the year-ago period.

The company hit a bump in the December quarter sequentially.

Midcap and smallcap stocks failed to perform, as their sectoral indices suffered losses of up to 0.33%.

The brokerage firm downgraded TCS citing expensive valuations.